세계의 피부 이식 시장 : 이식편 유형, 제품 유형, 용도, 최종사용자, 지역별(-2034년)

Global Skin Graft Market Research Report Information by Graft Type (Autograft, Allograft, Xenograft), by Product Type (Dermatome, Wound Debridement Device, Others), by Application (Pressure & Venous Ulcers, Diabetic Foot Ulcers, Burns, Surgical Wounds, Others), by End User (Hospitals, Ambulatory Surgery Centers, Specialty Centers), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Forecast till 2034

Industry Overview

By 2034, the Global Skin Graft Market is expected to attain a valuation of USD 2,619.58 million, expanding at a steady CAGR of 6.59% during the forecast period. Skin grafting involves taking healthy skin from a donor site and transplanting it to an injured or defective area of the body. This medical procedure helps repair and regenerate skin after burns, trauma, or surgeries.

The global skin graft market is driven by the rising number of chronic wounds like diabetic foot ulcer and pressure ulcer diseases. The rise in diabetes, obesity, and vascular diseases have led to a considerable demand for advanced healing modalities. The skin grafts are quite effective in repairing tissue and combating infections. Advances in surgical technologies like bioengineering skin grafts and stem cell skin grafts have shown to be efficient in recovery and have led to an increase in longitudinal demand and technological advancement in the market.

Major Company Development

The major company development in Surtex Instruments is a global expansion of market presence through cooperation and tradeshows, the launch of the Infinex microsurgery series, and compliance with ISO 13485 Quality Management Standard. Surtex's continuous investment in the development of innovative products, sustainable practices, and innovation driven by customer needs has fortified the company's intent to provide reliable and cost-effective surgical solutions across diverse specialities around the world.

Key Players

Major players in the global skin graft market are De Soutter Medical, B. Braun SE, Zimmer Biomet Holdings, Inc., Shaanxi Xingmao Industry Co., Ltd, Integra LifeSciences, AYGUN, Paramount Surgimed Ltd., Ribbel International Limited, Novo Surgical, Inc., and Surtex Instruments.

Report Attribute Details

• Market Size 2024: USD 1,379.84 Million
• Market Size 2034: USD 2,619.58 Million
• CAGR (2025-2034): 6.59%
• Base Year: 2024
• Market Forecast Period: 2025-2034

Industry Segmentations

• By Graft Type: Autograft - 6.95%, Allograft - 6.29%.
• By Product Type: Dermatome - 6.97%, Wound Debridement Device - 6.37%.
• By Application: Pressure & Venous Ulcers - 6.30%, Diabetic Foot Ulcers - 7.34%.
• By End User: Hospitals - 6.09%, Ambulatory Surgery Centers - 7.52%.

Regional Analysis

The United States remains a dominant region with a good base of advanced healthcare facilities, a thorough knowledge of the patients, and a large population group afflicted with chronic wound diseases. Canada is also showing good promise due to the friendly policies of the government ahead and advancements in techniques for wound management.

Germany, the UK, and France are becoming leaders in the presence of bioengineered skin and graft materials. The favourable health policy, coupled with increasing patient information, leads to a sound base for good longevity in growth in Europe.

Asia Pacific market value is expected to be USD 273.60 million in 2024 in the region and is likely to become the fastest growing section of the table at a healthy 7.55 percent CAGR. Government supported the health initiatives and advances in regenerative medicine also remains a growth area in the region.

The Latin America Skin Graft Market recorded a valuation of USD 86.50 million in 2024 and is projected to expand at a CAGR of 5.41%. Countries such as Brazil and Mexico are driving growth with an increasing focus on modern wound care practices. The region is gradually integrating advanced surgical techniques and bioengineered graft materials.

In 2024, the Middle East & Africa Skin Graft Market reached USD 66.73 million and is projected to grow at a CAGR of 4.99%. Market expansion is supported by the rise in reconstructive surgeries, improving healthcare standards, and growing investments in hospital infrastructure. GCC countries, particularly the UAE and Saudi Arabia, are key contributors, while South Africa is emerging as a notable market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW
• 1.2 MARKET ATTRACTIVENESS ANALYSIS
• 1.3 GLOBAL SKIN GRAFT MARKET, BY GRAFT TYPE
• 1.4 GLOBAL SKIN GRAFT MARKET, BY PRODUCT TYPE
• 1.5 GLOBAL SKIN GRAFT MARKET, BY APPLICATION
• 1.6 GLOBAL SKIN GRAFT MARKET, BY END USER
• 1.7 GLOBAL SKIN GRAFT MARKET, BY REGION

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TYPE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 INCREASING PREVALENCE OF CHRONIC WOUNDS
  • 4.2.2 AVAILABILITY OF REIMBURSEMENT FOR SKIN GRAFTING
• 4.3 RESTRAINTS
  • 4.3.1 RISKS AND COMPLICATIONS ASSOCIATED WITH SKIN GRAFT
• 4.4 OPPORTUNITY
  • 4.4.1 GROWING GERIATRIC POPULATION

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 THREAT OF SUBSTITUTES
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL SKIN GRAFT MARKET

6 GLOBAL SKIN GRAFT MARKET, BY GRAFT TYPE

• 6.1 OVERVIEW
• 6.2 AUTOGRAFT
• 6.3 ALLOGRAFT
• 6.4 XENOGRAFT

7 GLOBAL SKIN GRAFT MARKET, BY PRODUCT TYPE

• 7.1 OVERVIEW
• 7.2 DERMATOME
• 7.3 WOUND DEBRIDEMENT DEVICES
• 7.4 OTHERS

8 GLOBAL SKIN GRAFT MARKET, BY APPLICATION

• 8.1 OVERVIEW
• 8.2 PRESSURE & VENOUS ULCERS
• 8.3 DIABETIC FOOT ULCERS
• 8.4 BURNS
• 8.5 SURGICAL WOUNDS
• 8.6 OTHERS

9 GLOBAL SKIN GRAFT MARKET, BY END USER

• 9.1 OVERVIEW
• 9.2 HOSPITALS
• 9.3 AMBULATORY SURGERY CENTERS
• 9.4 SPECIALTY CENTERS

10 GLOBAL SKIN GRAFT MARKET, BY REGION

• 10.1 OVERVIEW
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 CANADA
• 10.3 EUROPE
  • 10.3.1 GERMANY
  • 10.3.2 UK
  • 10.3.3 FRANCE
  • 10.3.4 RUSSIA
  • 10.3.5 ITALY
  • 10.3.6 SPAIN
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA-PACIFIC
  • 10.4.1 CHINA
  • 10.4.2 INDIA
  • 10.4.3 JAPAN
  • 10.4.4 SOUTH KOREA
  • 10.4.5 MALAYSIA
  • 10.4.6 THAILAND
  • 10.4.7 INDONESIA
  • 10.4.8 REST OF ASIA-PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 BRAZIL
  • 10.5.2 MEXICO
  • 10.5.3 ARGENTINA
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 GCC COUNTRIES
  • 10.6.2 SOUTH AFRICA
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 MARKET SHARE ANALYSIS, 2024
• 11.3 COMPETITOR DASHBOARD
• 11.4 PUBLIC PLAYERS STOCK SUMMARY
• 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL

12 COMPANY PROFILES

• 12.1 B. BRAUN SE
  • 12.1.1 COMPANY OVERVIEW
  • 12.1.2 FINANCIAL OVERVIEW
  • 12.1.3 PRODUCTS OFFERED
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT ANALYSIS
  • 12.1.6 KEY STRATEGIES
• 12.2 ZIMMER BIOMET HOLDINGS, INC.
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 PRODUCTS OFFERED
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 SWOT ANALYSIS
  • 12.2.6 KEY STRATEGIES
• 12.3 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 12.3.1 COMPANY OVERVIEW
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCTS OFFERED
  • 12.3.4 KEY DEVELOPMENTS
  • 12.3.5 SWOT ANALYSIS
  • 12.3.6 KEY STRATEGIES
• 12.4 DE SOUTTER MEDICAL
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 FINANCIAL OVERVIEW
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 KEY DEVELOPMENTS
  • 12.4.5 SWOT ANALYSIS
  • 12.4.6 KEY STRATEGIES
• 12.5 SHAANXI XINGMAO INDUSTRY CO., LTD
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 FINANCIAL OVERVIEW
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 KEY STRATEGIES
• 12.6 AYGUN
  • 12.6.1 COMPANY OVERVIEW
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 KEY STRATEGIES
• 12.7 PARAMOUNT SURGIMED LTD
  • 12.7.1 COMPANY OVERVIEW
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 PRODUCTS OFFERED
  • 12.7.4 KEY DEVELOPMENTS
  • 12.7.5 KEY STRATEGIES
• 12.8 RIBBEL INTERNATIONAL LIMITED
  • 12.8.1 COMPANY OVERVIEW
  • 12.8.2 FINANCIAL OVERVIEW
  • 12.8.3 PRODUCTS OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 KEY STRATEGIES
• 12.9 NOVO SURGICAL, INC.
  • 12.9.1 COMPANY OVERVIEW
  • 12.9.2 FINANCIAL OVERVIEW
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 KEY STRATEGIES
• 12.10 SURTEX INSTRUMENTS
  • 12.10.1 COMPANY OVERVIEW
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 SWOT ANALYSIS
  • 12.10.6 KEY STRATEGIES

13 DATA CITATIONS